We are delighted to announce a significant business win with another pharmac eutical firm. Roche, the Swiss based pharma company, has contracted with us to deliver a research project for the design and delivery of exit interviews for regrettable leavers. The outcomes of the research project will help Roche to adjust its talent retention and talent management strategy to ensure that it maintains the employee engagement and commitment of key talent within its business.
An external and independently conducted interview is the best way to determine the reasons why regrettable leavers exit a business. Normal range HR exit interviews very often do not pinpoint the real reason why people will leave a company. There is too much at stake for the leaver to be totally honest in the exit interview, not least the need for a positive reference. We will provide an independent and externally referenced view of the reason for leaving.
We are delighted to further enhance our reputation within the pharmaceutical industry with the addition of another new pharma customer.
Roche is one of the worlds leading innovation-driven healthcare groups. Its core businesses are pharmaceuticals and diagnostics. Roche is number one in the global diagnostics market and is the leading supplier of pharmaceuticals for cancer and a leader in virology and transplantation. As a supplier of products and services for the prevention, diagnosis and treatment of disease, the Group contributes on a broad range of fronts to improving people’s health and quality of life. Roche employs roughly 74,000 people in 150 countries.
To read more about Roche Pharma, please click here.
|
